Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 8.55% is 38% above its 5-year average of 6.18%, near the high end of its 5-year range (-0.15%–11.41%).
3.89% above its 12-month average of 8.23%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 11.41%.
OPERATING MARGIN
8.55%
OPERATING MARGIN AVG TTM
8.23%
OPERATING MARGIN AVG 3Y
6.05%
OPERATING MARGIN AVG 5Y
6.18%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3.89%
CURRENT VS 3Y AVG
+41.32%
CURRENT VS 5Y AVG
+38.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$2.02B
Operating Margin
38.98%
TTM Avg
19.21%
3Y Avg
-11.92%
5Y Avg
-190.31%
Market Cap
$2.02B
Operating Margin
-113.73%
TTM Avg
-110.40%
3Y Avg
-105.71%
5Y Avg
-281.52%
Market Cap
$2.02B
Operating Margin
37.06%
TTM Avg
17.54%
3Y Avg
-25.09%
5Y Avg
-117.46%
Market Cap
$2.05B
Operating Margin
5.95%
TTM Avg
2.95%
3Y Avg
-1.94%
5Y Avg
-1.81%
Market Cap
$2.06B
Operating Margin
-19160.00%
TTM Avg
-10969.44%
3Y Avg
-7268.29%
5Y Avg
-5243.17%
Market Cap
$2.06B
Operating Margin
-512.91%
TTM Avg
-49765.56%
3Y Avg
-47036.35%
5Y Avg
-33558.09%
Market Cap
$1.98B
Operating Margin
0.41%
TTM Avg
-3.56%
3Y Avg
0.15%
5Y Avg
-1.31%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Progyny, Inc. (PGNY) | $2.03B | 8.55% | 8.23% | 6.05% | 6.18% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.02B | 38.98% | 19.21% | -11.92% | -190.31% |
| UroGen Pharma Ltd. (URGN)vs › | $2.02B | -113.73% | -110.40% | -105.71% | -281.52% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 37.06% | 17.54% | -25.09% | -117.46% |
| Vericel Corporation (VCEL)vs › | $2.05B | 5.95% | 2.95% | -1.94% | -1.81% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | -19160.00% | -10969.44% | -7268.29% | -5243.17% |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | -512.91% | -49765.56% | -47036.35% | -33558.09% |
| Alvotech (ALVO)vs › | $2.08B | 9.62% | 13.78% | -194.45% | -270.76% |
| Fortrea Holdings Inc. (FTRE)vs › | $1.98B | 0.41% | -3.56% | 0.15% | -1.31% |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.97B | 6.02% | 5.04% | -2.01% | -12.30% |
Gross Margin
24.6%
Operating Margin
8.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 11.41% |
| 2026-03-31 | 10.77% |
| 2025-12-31 | 4.78% |
| 2025-09-30 | 6.87% |
| 2025-06-30 | 7.32% |
| 2025-03-31 | 7.46% |
| 2024-12-31 | 5.29% |
| 2024-09-30 | 4.35% |
| 2024-06-30 | 6.80% |
| 2024-03-31 | 6.66% |
| 2023-12-31 | 5.11% |
| 2023-09-30 | 6.48% |
| 2023-06-30 | 5.44% |
| 2023-03-31 | 5.81% |
| 2022-12-31 | 1.54% |
| 2022-09-30 | 5.48% |
| 2022-06-30 | 4.53% |
| 2022-03-31 | -0.03% |
| 2021-12-31 | -0.15% |
| 2021-09-30 | 7.41% |
| 2021-06-30 | 9.06% |
| 2021-03-31 | 9.67% |
| 2020-12-31 | 0.95% |
| 2020-09-30 | 4.88% |
| 2020-06-30 | -1.66% |
| 2020-03-31 | 4.23% |
| 2019-12-31 | 1.76% |
| 2019-09-30 | 5.02% |
| 2019-06-30 | 4.19% |
| 2019-03-31 | 6.59% |
| 2018-12-31 | -2.41% |
| 2018-09-30 | -2.11% |
| 2018-06-30 | -1.21% |
| 2018-03-31 | -8.29% |
